Targeted therapies in the management of renal cell carcinoma: role of bevacizumab

بواسطة Escudier, Bernard, Cosaert, Jan, Jethwa, Sangeeta
منشور في 2008

Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC

بواسطة Gerber, David E., Swanson, Paul, Lopez-Chavez, Ariel, Wong, Lucas, Dowlati, Afshin, Pennell, Nathan A., Cronier, Damien M., Qin, Amy, Ilaria, Robert, Cosaert, Jan, Shahir, Ashwin, Baggstrom, Maria Q.
الحاوية / القاعدة Lung Cancer (2017)

Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors

بواسطة LoRusso, Patricia M., Gounder, Mrinal, Jalal, Shadia I., André, Valérie, Kambhampati, Siva Rama Prasad, Loizos, Nick, Hall, Jennifer, Holzer, Timothy R., Nasir, Aejaz, Cosaert, Jan, Kauh, John, Chiorean, E. Gabriela
الحاوية / القاعدة Invest New Drugs (2017)

A Phase 1 Study of Anti-TGFβ Receptor Type-II Monoclonal Antibody LY3022859 in Patients with Advanced Solid Tumors

بواسطة Tolcher, Anthony W., Berlin, Jordan D., Cosaert, Jan, Kauh, John, Chan, Emily, Piha-Paul, Sarina A., Amaya, Alex, Tang, Shande, Driscoll, Kyla, Kimbung, Richard, Prasad Kambhampati, S. R., Gueorguieva, Ivelina, Hong, David S.
الحاوية / القاعدة Cancer Chemother Pharmacol (2017)

Clinical and Translational Results of a Phase II, Randomized Trial of an Anti–IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy

بواسطة Gradishar, William J., Yardley, Denise A., Layman, Rachel, Sparano, Joseph A., Chuang, Ellen, Northfelt, Donald W., Schwartz, Gary N., Youssoufian, Hagop, Tang, Shande, Novosiadly, Ruslan, Forest, Amelie, Nguyen, Tuan S., Cosaert, Jan, Grebennik, Dmitri, Haluska, Paul
الحاوية / القاعدة Clin Cancer Res (2015)

An Open-label, Dose-Escalation Phase 1 Study of anti-TYRP1 monoclonal antibody IMC-20D7S for patients with relapsed or refractory melanoma

بواسطة Khalil, Danny N., Postow, Michael A., Ibrahim, Nageatte, Ludwig, Dale L., Cosaert, Jan, Kambhampati, Siva Rama Prasad, Tang, Shande, Grebennik, Dmitri, Kauh, John Sae Wook, Lenz, Heinz-Josef, Flaherty, Keith T., Hodi, F. Stephen, Lawrence, Donald P., Wolchok, Jedd D.
الحاوية / القاعدة Clin Cancer Res (2016)

Olaratumab and doxorubicin versus doxorubicin alone in soft tissue sarcoma

بواسطة Tap, William D., Jones, Robin L., Van Tine, Brian A., Chmielowski, Bartosz, Elias, Anthony D., Adkins, Douglas, Agulnik, Mark, Cooney, Matthew M., Livingston, Michael B., Pennock, Gregory, Hameed, Meera R., Shah, Gaurav D., Qin, Amy, Shahir, Ashwin, Cronier, Damien M., Ilaria, Robert, Conti, Ilaria, Cosaert, Jan, Schwartz, Gary K.
الحاوية / القاعدة Lancet (2016)